Product Name :
SSE15206
Description:
SSE15206 is a microtubule depolymerizing agent which inhibits microtubule polymerization both in biochemical and cellular assays by binding to colchicine site in tubulin. It causes aberrant mitosis resulting in G2/M arrest due to incomplete spindle formation.
CAS:
1370046-40-4
Molecular Weight:
371.45
Formula:
C19H21N3O3S
Chemical Name:
4,5-Dihydro-3-phenyl-5-(3,4,5-trimethoxyphenyl)-1H-pyrazole-1-carbothioamide
Smiles :
COC1C=C(C=C(OC)C=1OC)C1CC(=NN1C(N)=S)C1C=CC=CC=1
InChiKey:
GONIBFCARADPAC-UHFFFAOYSA-N
InChi :
InChI=1S/C19H21N3O3S/c1-23-16-9-13(10-17(24-2)18(16)25-3)15-11-14(21-22(15)19(20)26)12-7-5-4-6-8-12/h4-10,15H,11H2,1-3H3,(H2,20,26)
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
SSE15206 is a microtubule depolymerizing agent which inhibits microtubule polymerization both in biochemical and cellular assays by binding to colchicine site in tubulin. It causes aberrant mitosis resulting in G2/M arrest due to incomplete spindle formation.{{Netarsudil dimesylate} site|{Netarsudil dimesylate} Stem Cell/Wnt|{Netarsudil dimesylate} Technical Information|{Netarsudil dimesylate} Data Sheet|{Netarsudil dimesylate} manufacturer|{Netarsudil dimesylate} Epigenetics} |Product information|CAS Number: 1370046-40-4|Molecular Weight: 371.{{Dihydroergotamine} MedChemExpress|{Dihydroergotamine} 5-HT Receptor|{Dihydroergotamine} Biological Activity|{Dihydroergotamine} Data Sheet|{Dihydroergotamine} custom synthesis|{Dihydroergotamine} Cancer} 45|Formula: C19H21N3O3S|Chemical Name: 4,5-Dihydro-3-phenyl-5-(3,4,5-trimethoxyphenyl)-1H-pyrazole-1-carbothioamide|Smiles: COC1C=C(C=C(OC)C=1OC)C1CC(=NN1C(N)=S)C1C=CC=CC=1|InChiKey: GONIBFCARADPAC-UHFFFAOYSA-N|InChi: InChI=1S/C19H21N3O3S/c1-23-16-9-13(10-17(24-2)18(16)25-3)15-11-14(21-22(15)19(20)26)12-7-5-4-6-8-12/h4-10,15H,11H2,1-3H3,(H2,20,26)|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Solubility: DMSO: 74 mg/mL(199.PMID:23927631 21 mM). Water: Insoluble.|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vitro:|Treatment of cells with SSE15206 causes aberrant mitosis resulting in G2/M arrest due to incomplete spindle formation, a phenotype often associated with drugs that interfere with microtubule dynamics. SSE15206 inhibits microtubule polymerization both in biochemical and cellular assays by binding to colchicine site in tubulin. Prolonged treatment of cells with SSE15206 results in apoptotic cell death accompanied by p53 induction.|References:|Manzoor S, et al. Identification and characterization of SSE15206, a microtubule depolymerizing agent that overcomes multidrug resistance. Sci Rep. 2018 Feb 19;8(1):3305.Products are for research use only. Not for human use.|
